The neuropeptide y system: Pathophysiological and therapeutic implications in obesity and cancer

Pharmacology and Therapeutics

Volumn 131, Issue 1, 2011, Pages 91-113

  Zhang, Lei ^a   Bijker, Martijn S ^a   Herzog, Herbert ^a,b,c  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Cancer; Neuropeptide Y; Obesity; Peptide YY; Y receptors

Indexed keywords

1 NAPHTHALENESULFONIC ACID [4 [(4 AMINO 2 QUINAZOLINYLAMINO)METHYL]CYCLOHEXYLMETHYL]AMIDE; 1229U 91; 3 OXO N(5 PHENYLPYRAZINYL)SPIRO[ISOBENZOFURAN 1 (3H),4' PIPERIDINE] 1' CARBOXAMIDE; ANOREXIGENIC AGENT; ANTIOBESITY AGENT; BMS 193885; CPG 71683A; FMS 586; GR 231118; GW 438014A; INSULIN; J 104870; L 152 804; MK 0577; N [1 [4 [[[[4 [(DIMETHYLAMINO)METHYL]CYCLOHEXYL]METHYL]AMINO]IMINOMETHYL]BENZYL] 2 OXO 2 (1 PYRROLIDINYL)ETHYL] ALPHA [(2 NAPHTHALENYLSULFONYL)AMINO]BENZENEPROPANAMIDE; N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR ANTAGONIST; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR ANTAGONIST; NEUROPEPTIDE Y4 RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR AGONIST; PANCREAS POLYPEPTIDE; PEPTIDE YY; S 25585; UNCLASSIFIED DRUG; UNINDEXED DRUG; VELNEPERIT;

ANOREXIA; APPETITE; ARCUATE NUCLEUS; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER RISK; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DYSLIPIDEMIA; ENERGY BALANCE; ENERGY EXPENDITURE; EWING SARCOMA; FOOD INTAKE; GENE DELETION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE SILENCING; GENETIC VARIABILITY; HORMONAL REGULATION; HUMAN; HYPERGLYCEMIA; HYPERPHAGIA; HYPERTENSION; INSULIN RELEASE; INTESTINE SECRETION; KNOCKOUT MOUSE; LIPID OXIDATION; METABOLIC REGULATION; NEOPLASM; NEUROBLASTOMA; NEUROTRANSMISSION; NONHUMAN; OBESITY; PANCREAS CANCER; PATHOPHYSIOLOGY; PHEOCHROMOCYTOMA; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; RECEPTOR AFFINITY; SATIETY; WEIGHT REDUCTION;

EID: 79956188407     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2011.03.011     Document Type: Review

References (344)

1. C.R. Abbott, C.J. Small, A.R. Kennedy, N.M. Neary, A. Sajedi, and M.A. Ghatei Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake Brain Res 1043 1-2 2005 139 144 (Pubitemid 40603381)
2. T.L. Abell, J.R. Malagelada, A.R. Lucas, M.L. Brown, M. Camilleri, and V.L. Go Gastric electromechanical and neurohormonal function in anorexia nervosa Gastroenterology 93 5 1987 958 965 (Pubitemid 18000637)
3. K. Abid, B. Rochat, P.G. Lassahn, R. Stocklin, S. Michalet, and N. Brakch Kinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35: a new peptide generated by plasma kallikrein J Biol Chem 284 37 2009 24715 24724
4. C. Acuna-Goycolea, and A.N. van den Pol Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis J Neurosci 25 45 2005 10510 10519 (Pubitemid 41628453)
5. S.H. Adams, C. Lei, C.M. Jodka, S.E. Nikoulina, J.A. Hoyt, and B. Gedulin PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice J Nutr 136 1 2006 195 201 (Pubitemid 43156508)
6. S.H. Adams, W.B. Won, S.E. Schonhoff, A.B. Leiter, and J.R. Paterniti Effects of peptide YY[3-36] on short-term food intake in mice are not affected by prevailing plasma ghrelin levels Endocrinology 145 11 2004 4967 4975 (Pubitemid 39551114)
7. T.E. Adrian Pancreatic polypeptide J Clin Pathol Suppl (Assoc Clin Pathol) 8 1978 43 50
8. T.E. Adrian, G.R. Greenberg, M.L. Fitzpatrick, and S.R. Bloom Lack of effect of pancreatic polypeptide in the rate of gastric emptying and gut hormone release during breakfast Digestion 21 4 1981 214 218 (Pubitemid 11183917)
9. R.S. Ahima, D. Prabakaran, C. Mantzoros, D. Qu, B. Lowell, and E. Maratos-Flier Role of leptin in the neuroendocrine response to fasting Nature 382 6588 1996 250 252 (Pubitemid 26251358)
10. A. Akabayashi, N. Levin, X. Paez, J.T. Alexander, and S.F. Leibowitz Hypothalamic neuropeptide Y and its gene expression: relation to light/dark cycle and circulating corticosterone Mol Cell Neurosci 5 3 1994 210 218 (Pubitemid 24172503)
11. A. Akabayashi, C. Wahlestedt, J.T. Alexander, and S.F. Leibowtiz Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion Brain Res Mol Brain Res 21 1-2 1994 55 61
12. A. Akabayashi, C.T. Zaia, I. Silva, H.J. Chae, and S.F. Leibowitz Neuropeptide Y in the arcuate nucleus is modulated by alterations in glucose utilization Brain Res 621 2 1993 343 348 (Pubitemid 23248096)
13. J.T. Alderdice, W.W. Dinsmore, K.D. Buchanan, and C. Adams Gastrointestinal hormones in anorexia nervosa J Psychiatr Res 19 2-3 1985 207 213 (Pubitemid 16240007)
14. J.M. Allen, J.C. Yeats, R. Causon, M.J. Brown, and S.R. Bloom Neuropeptide Y and its flanking peptide in human endocrine tumors and plasma J Clin Endocrinol Metab 64 6 1987 1199 1204 (Pubitemid 17074779)
15. S.J. Allison, P. Baldock, A. Sainsbury, R. Enriquez, N.J. Lee, and E.J. Lin Conditional deletion of hypothalamic Y2 receptors reverts gonadectomy-induced bone loss in adult mice J Biol Chem 281 33 2006 23436 23444 (Pubitemid 44274118)
16. M. Alvarez Bartolome, M. Borque, J. Martinez-Sarmiento, E. Aparicio, C. Hernandez, and L. Cabrerizo Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty Obes Surg 12 3 2002 324 327 (Pubitemid 34621023)
17. I. Antal-Zimanyi, M.A. Bruce, K.L. Leboulluec, L.G. Iben, G.K. Mattson, and R.T. McGovern Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist Eur J Pharmacol 590 1-3 2008 224 232
18. A. Asakawa, A. Inui, T. Kaga, H. Yuzuriha, T. Nagata, and N. Ueno Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin Gastroenterology 120 2 2001 337 345 (Pubitemid 32149296)
19. A. Asakawa, A. Inui, N. Ueno, M. Fujimiya, M.A. Fujino, and M. Kasuga Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice Peptides 20 12 1999 1445 1448 (Pubitemid 30069890)
20. A. Asakawa, A. Inui, H. Yuzuriha, N. Ueno, G. Katsuura, and M. Fujimiya Characterization of the effects of pancreatic polypeptide in the regulation of energy balance Gastroenterology 124 5 2003 1325 1336 (Pubitemid 36531807)
21. F.L. Bai, M. Yamano, Y. Shiotani, P.C. Emson, A.D. Smith, and J.F. Powell An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat Brain Res 331 1 1985 172 175 (Pubitemid 15115377)
22. A. Balasubramaniam Neuropeptide Y family of hormones: receptor subtypes and antagonists Peptides 18 3 1997 445 457 (Pubitemid 27224378)
23. A. Balasubramaniam, D.E. Mullins, S. Lin, W. Zhai, Z. Tao, and V.C. Dhawan Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity J Med Chem 49 8 2006 2661 2665
24. A. Balasubramaniam, Z. Tao, W. Zhai, M. Stein, S. Sheriff, and W.T. Chance Structure-activity studies including a Psi(CH(2)-NH) scan of peptide YY (PYY) active site, PYY(22-36), for interaction with rat intestinal PYY receptors: development of analogues with potent in vivo activity in the intestine J Med Chem 43 18 2000 3420 3427
25. P.A. Baldock, S.J. Allison, P. Lundberg, N.J. Lee, K. Slack, and E.J. Lin Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis J Biol Chem 282 26 2007 19092 19102 (Pubitemid 47100174)
26. P.A. Baldock, A. Sainsbury, M. Couzens, R.F. Enriquez, G.P. Thomas, and E.M. Gardiner Hypothalamic Y2 receptors regulate bone formation J Clin Invest 109 7 2002 915 921 (Pubitemid 34275112)
27. G.H. Ballantyne Peptide YY(1-36) and peptide YY(3-36): part II. Changes after gastrointestinal surgery and bariatric surgery Obes Surg 16 6 2006 795 803 (Pubitemid 43874841)
28. E.D. Baraboi, C. Michel, P. Smith, K. Thibaudeau, A.V. Ferguson, and D. Richard Effects of albumin-conjugated PYY on food intake: the respective roles of the circumventricular organs and vagus nerve Eur J Neurosci 16 2010 16
29. B. Baranowska, E. Wolinska-Witort, L. Martynska, M. Chmielowska, and A. Baranowska-Bik Plasma orexin A, orexin B, leptin, neuropeptide Y (NPY) and insulin in obese women Neuro Endocrinol Lett 26 4 2005 293 296 (Pubitemid 41518763)
30. B. Baranowska, E. Wolinska-Witort, E. Wasilewska-Dziubinska, K. Roguski, L. Martynska, and M. Chmielowska The role of neuropeptides in the disturbed control of appetite and hormone secretion in eating disorders Neuro Endocrinol Lett 24 6 2003 431 434 (Pubitemid 38035091)
31. J.A. Bard, M.W. Walker, T.A. Branchek, and R.L. Weinshank Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY J Biol Chem 270 45 1995 26762 26765
32. R.L. Batterham, M.A. Cohen, S.M. Ellis, C.W. Le Roux, D.J. Withers, and G.S. Frost Inhibition of food intake in obese subjects by peptide YY3-36 N Engl J Med 349 10 2003 941 948 (Pubitemid 37064767)
33. R.L. Batterham, M.A. Cowley, C.J. Small, H. Herzog, M.A. Cohen, and C.L. Dakin Gut hormone PYY(3-36) physiologically inhibits food intake Nature 418 6898 2002 650 654
34. R.L. Batterham, H. Heffron, S. Kapoor, J.E. Chivers, K. Chandarana, and H. Herzog Critical role for peptide YY in protein-mediated satiation and body-weight regulation Cell Metab 4 3 2006 223 233 (Pubitemid 44307976)
35. R.L. Batterham, C.W. Le Roux, M.A. Cohen, A.J. Park, S.M. Ellis, and M. Patterson Pancreatic polypeptide reduces appetite and food intake in humans J Clin Endocrinol Metab 88 8 2003 3989 3992 (Pubitemid 37034556)
36. O.B. Bchini-Hooft van Huijsduijnen, F. Rohner-Jeanrenaud, and B. Jeanrenaud Hypothalamic neuropeptide Y messenger ribonucleic acid levels in pre-obese and genetically obese (fa/fa) rats; potential regulation thereof by corticotropin-releasing factor J Neuroendocrinol 5 4 1993 381 386 (Pubitemid 23243496)
37. M.M. Berglund, P.A. Hipskind, and D.R. Gehlert Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes Exp Biol Med (Maywood) 228 3 2003 217 244 (Pubitemid 36314489)
38. G.G. Berntson, W.B. Zipf, T.M. O'Dorisio, J.A. Hoffman, and R.E. Chance Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome Peptides 14 3 1993 497 503
39. A.C. Bianco, A.L. Maia, W.S. da Silva, and M.A. Christoffolete Adaptive activation of thyroid hormone and energy expenditure Biosci Rep 25 3-4 2005 191 208 (Pubitemid 41613787)
40. C.J. Billington, J.E. Briggs, M. Grace, and A.S. Levine Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism Am J Physiol 260 2 Pt 2 1991 R321 R327
41. C.J. Billington, J.E. Briggs, S. Harker, M. Grace, and A.S. Levine Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism Am J Physiol 266 6 Pt 2 1994 R1765 R1770
42. M.H. Block, S. Boyer, W. Brailsford, D.R. Brittain, D. Carroll, and S. Chapman Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesity J Med Chem 45 16 2002 3509 3523 (Pubitemid 34824039)
43. A.G. Blomqvist, and H. Herzog Y-receptor subtypes-how many more? Trends Neurosci 20 7 1997 294 298
44. D. Boey, L. Heilbronn, A. Sainsbury, R. Laybutt, A. Kriketos, and H. Herzog Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes Neuropeptides 40 5 2006 317 324 (Pubitemid 44634710)
45. D. Boey, S. Lin, R.F. Enriquez, N.J. Lee, K. Slack, and M. Couzens PYY transgenic mice are protected against diet-induced and genetic obesity Neuropeptides 42 1 2008 19 30
46. D. Boey, S. Lin, T. Karl, P. Baldock, N. Lee, and R. Enriquez Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity Diabetologia 49 6 2006 1360 1370
47. P. Bonaventure, D. Nepomuceno, C. Mazur, B. Lord, D.A. Rudolph, and J.A. Jablonowski Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3- cyano-phenyl)-N-[1-(2-cyclopen tyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a small molecule antagonist of the neuropeptide Y Y2 receptor J Pharmacol Exp Ther 308 3 2004 1130 1137 (Pubitemid 38263990)
48. R.R. Bowers, W.T. Festuccia, C.K. Song, H. Shi, R.H. Migliorini, and T.J. Bartness Sympathetic innervation of white adipose tissue and its regulation of fat cell number Am J Physiol Regul Integr Comp Physiol 286 6 2004 R1167 R1175
49. R.L. Bradley, J.P. Mansfield, and E. Maratos-Flier Neuropeptides, including neuropeptide Y and melanocortins, mediate lipolysis in murine adipocytes Obes Res 13 4 2005 653 661
50. R.D. Broadwell, and M.W. Brightman Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood J Comp Neurol 166 3 1976 257 283
51. C. Broberger, T.J. Visser, M.J. Kuhar, and T. Hokfelt Neuropeptide Y innervation and neuropeptide-Y-Y1-receptor-expressing neurons in the paraventricular hypothalamic nucleus of the mouse Neuroendocrinology 70 5 1999 295 305
52. C.R. Bruce, A.J. Hoy, N. Turner, M.J. Watt, T.L. Allen, and K. Carpenter Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance Diabetes 58 3 2009 550 558
53. R. Burcelin, H. Brunner, J. Seydoux, B. Thorensa, and T. Pedrazzini Increased insulin concentrations and glucose storage in neuropeptide Y Y1 receptor-deficient mice Peptides 22 3 2001 421 427 (Pubitemid 32250243)
54. C. Cabrele, M. Langer, R. Bader, H.A. Wieland, H.N. Doods, and O. Zerbe The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats J Biol Chem 275 46 2000 36043 36048
55. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 17 2003 1625 1638 (Pubitemid 36459468)
56. I. Castan, P. Valet, N. Quideau, T. Voisin, L. Ambid, and M. Laburthe Antilipolytic effects of alpha 2-adrenergic agonists, neuropeptide Y, adenosine, and PGE1 in mammal adipocytes Am J Physiol 266 4 Pt 2 1994 R1141 R1147
57. C. Catzeflis, D.D. Pierroz, F. Rohner-Jeanrenaud, J.E. Rivier, P.C. Sizonenko, and M.L. Aubert Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats Endocrinology 132 1 1993 224 234 (Pubitemid 23019506)
58. J.M. Cerda-Reverter, and D. Larhammar Neuropeptide Y family of peptides: structure, anatomical expression, function, and molecular evolution Biochem Cell Biol 78 3 2000 371 392
59. B.G. Challis, A.P. Coll, G.S. Yeo, S.B. Pinnock, S.L. Dickson, and R.R. Thresher Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36) Proc Natl Acad Sci U S A 101 13 2004 4695 4700 (Pubitemid 38437473)
60. Y.Y. Chan, R.A. Steiner, and D.K. Clifton Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat Endocrinology 137 4 1996 1319 1325 (Pubitemid 26095248)
61. W.T. Chance, S. Sheriff, F. Peng, and A. Balasubramaniam Antagonism of NPY-induced feeding by pretreatment with cyclic AMP response element binding protein antisense oligonucleotide Neuropeptides 34 3-4 2000 167 172
62. W.T. Chance, C. Xiao, R. Dayal, and S. Sheriff Alteration of NPY and Y1 receptor in dorsomedial and ventromedial areas of hypothalamus in anorectic tumor-bearing rats Peptides 28 2 2007 295 301 (Pubitemid 46176260)
63. P.K. Chelikani, A.C. Haver, J.R. Reeve Jr.; D.A. Keire, and R.D. Reidelberger Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats Am J Physiol Regul Integr Comp Physiol 290 2 2006 R298 R305
64. N. Chen, L. Liu, Y. Zhang, H.N. Ginsberg, and Y.H. Yu Whole-body insulin resistance in the absence of obesity in FVB mice with overexpression of Dgat1 in adipose tissue Diabetes 54 12 2005 3379 3386 (Pubitemid 43334326)
65. J.T. Clark, P.S. Kalra, W.R. Crowley, and P.; K. S. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats Endocrinology 115 1 1984 427 429 (Pubitemid 14086844)
66. H.M. Cox, I.R. Tough, A.M. Woolston, L. Zhang, A.D. Nguyen, and A. Sainsbury Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses Cell Metab 11 6 2010 532 542
67. L. Criscione, P. Rigollier, C. Batzl-Hartmann, H. Rueger, A. Stricker-Krongrad, and P. Wyss Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor J Clin Invest 102 12 1998 2136 2145 (Pubitemid 29018820)
68. P.J. Currie, and D.V. Coscina Dissociated feeding and hypothermic effects of neuropeptide Y in the paraventricular and perifornical hypothalamus Peptides 16 4 1995 599 604
69. I. Cusin, J. Terrettaz, F. Rohner-Jeanrenaud, and B. Jeanrenaud Metabolic consequences of hyperinsulinaemia imposed on normal rats on glucose handling by white adipose tissue, muscles and liver Biochem J 267 1 1990 99 103 (Pubitemid 20122641)
70. A.J. Daniels, M.K. Grizzle, R.P. Wiard, J.E. Matthews, and D. Heyer Food intake inhibition and reduction in body weight gain in lean and obese rodents treated with GW438014A, a potent and selective NPY-Y5 receptor antagonist Regul Pept 106 1-3 2002 47 54 (Pubitemid 34607337)
71. A.J. Daniels, J.E. Matthews, R.J. Slepetis, M. Jansen, O.H. Viveros, and A. Tadepalli High-affinity neuropeptide Y receptor antagonists Proc Natl Acad Sci U S A 92 20 1995 9067 9071
72. L. Degen, S. Oesch, M. Casanova, S. Graf, S. Ketterer, and J. Drewe Effect of peptide YY3-36 on food intake in humans Gastroenterology 129 5 2005 1430 1436 (Pubitemid 41597385)
73. O. Della Zuana, M. Sadlo, M. Germain, M. Feletou, S. Chamorro, and F. Tisserand Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockade Int J Obes Relat Metab Disord 25 1 2001 84 94 (Pubitemid 32142388)
74. O. Della-Zuana, L. Revereault, A. Beck-Sickinger, A. Monge, D.H. Caignard, and J.L. Fauchere A potent and selective NPY Y5 antagonist reduces food intake but not through blockade of the NPY Y5 receptor Int J Obes Relat Metab Disord 28 4 2004 628 639 (Pubitemid 38491157)
75. P. deS Senanayake, J. Denker, E.L. Bravo, and R.M. Graham Production, characterization, and expression of neuropeptide Y by human pheochromocytoma J Clin Invest 96 5 1995 2503 2509
76. B. Ding, B. Kull, Z. Liu, S. Mottagui-Tabar, H. Thonberg, and H.F. Gu Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function Regul Pept 127 1-3 2005 45 53 (Pubitemid 40179241)
77. H. Doods, W. Gaida, H.A. Wieland, H. Dollinger, G. Schnorrenberg, and F. Esser BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist Eur J Pharmacol 384 2-3 1999 R3 R5
78. H.N. Doods, W. Wienen, M. Entzeroth, K. Rudolf, W. Eberlein, and W. Engel Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226 J Pharmacol Exp Ther 275 1 1995 136 142
79. A.G. Dulloo, and L. Girardier Adaptive changes in energy expenditure during refeeding following low-calorie intake: evidence for a specific metabolic component favoring fat storage Am J Clin Nutr 52 3 1990 415 420
80. Y. Dumont, J.C. Martel, A. Fournier, S. St-Pierre, and R. Quirion Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues Prog Neurobiol 38 2 1992 125 167
81. Y. Dumont, E. Moyse, A. Fournier, and R. Quirion Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain J Pharmacol Exp Ther 315 1 2005 99 108 (Pubitemid 41380502)
82. J.C. Dunbar, E. Ergene, and R.A. Barraco Neuropeptide-Y stimulation of insulin secretion is mediated via the nucleus tractus solitarius Horm Metab Res 24 3 1992 103 105
83. M.M. Durkin, M.W. Walker, K.E. Smith, E.L. Gustafson, C. Gerald, and T.A. Branchek Expression of a novel neuropeptide Y receptor subtype involved in food intake: an in situ hybridization study of Y5 mRNA distribution in rat brain Exp Neurol 165 1 2000 90 100
84. M.E. Edelsbrunner, E. Painsipp, H. Herzog, and P. Holzer Evidence from knockout mice for distinct implications of neuropeptide-Y Y2 and Y4 receptors in the circadian control of locomotion, exploration, water and food intake Neuropeptides 43 6 2009 491 497
85. E. Ekblad, L. Edvinsson, C. Wahlestedt, R. Uddman, R. Hakanson, and F. Sundler Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers Regul Pept 8 3 1984 225 235 (Pubitemid 14109276)
86. E. Ekblad, and F. Sundler Distribution of pancreatic polypeptide and peptide YY Peptides 23 2 2002 251 261 (Pubitemid 34127963)
87. A.J. Ekstrand, R. Cao, M. Bjorndahl, S. Nystrom, A.C. Jonsson-Rylander, and H. Hassani Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing Proc Natl Acad Sci U S A 100 10 2003 6033 6038 (Pubitemid 36576926)
88. K.L. Ellacott, and R.D. Cone The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis Recent Prog Horm Res 59 2004 395 408
89. J.K. Elmquist, C. Bjorbaek, R.S. Ahima, J.S. Flier, and C.B. Saper Distributions of leptin receptor mRNA isoforms in the rat brain J Comp Neurol 395 4 1998 535 547 (Pubitemid 28226097)
90. P.J. Enriori, A.E. Evans, P. Sinnayah, E.E. Jobst, L. Tonelli-Lemos, and S.K. Billes Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons Cell Metab 5 3 2007 181 194
91. N. Erondu, I. Gantz, B. Musser, S. Suryawanshi, M. Mallick, and C. Addy Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults Cell Metab 4 4 2006 275 282 (Pubitemid 44430911)
92. N. Erondu, T. Wadden, I. Gantz, B. Musser, A.M. Nguyen, and H. Bays Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss Obesity (Silver Spring) 15 4 2007 895 905 (Pubitemid 46740965)
93. B.C. Fam, M.J. Morris, M.J. Hansen, S. Andrikopoulos, J. Proietto, and A.W. Thorburn Modulation of central leptin sensitivity and energy balance in a rat model of diet-induced obesity Diabetes Obes Metab 9 6 2007 840 852 (Pubitemid 47555205)
94. C. Fekete, J. Kelly, E. Mihaly, S. Sarkar, W.M. Rand, and G. Legradi Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary- thyroid axis Endocrinology 142 6 2001 2606 2613 (Pubitemid 32473117)
95. C. Fekete, S. Sarkar, W.M. Rand, J.W. Harney, C.H. Emerson, and A.C. Bianco Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis Endocrinology 143 12 2002 4513 4519 (Pubitemid 35397590)
96. S. Fetissov, J. Kopp, and T. Hokfelt Distribution of NPY receptors in the hypothalamus Neuropeptides 38 4 2004 175 188 (Pubitemid 39158858)
97. B.C. Field, A.M. Wren, V. Peters, K.C. Baynes, N.M. Martin, and M. Patterson PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans Diabetes 59 7 2010 1635 1639
98. J. Fuhlendorff, U. Gether, L. Aakerlund, N. Langeland-Johansen, H. Thogersen, and S.G. Melberg [Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist Proc Natl Acad Sci U S A 87 1 1990 182 186
99. I. Gantz, N. Erondu, M. Mallick, B. Musser, R. Krishna, and W.K. Tanaka Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults J Clin Endocrinol Metab 92 5 2007 1754 1757 (Pubitemid 46997183)
100. J. Gao, L. Ghibaudi, and J.J. Hwa Selective activation of central NPY Y1 vs. Y5 receptor elicits hyperinsulinemia via distinct mechanisms Am J Physiol Endocrinol Metab 287 4 2004 E706 E711
101. D.R. Gehlert, S.L. Gackenheimer, D.A. Schober, L. Beavers, R. Gadski, and J.P. Burnett The neuropeptide Y Y1 receptor selective radioligand, [125I][Leu31, Pro34]peptide YY, is also a high affinity radioligand for human pancreatic polypeptide 1 receptors Eur J Pharmacol 318 2-3 1996 485 490 (Pubitemid 27046647)
102. C. Gerald, M.W. Walker, L. Criscione, E.L. Gustafson, C. Batzl-Hartmann, and K.E. Smith A receptor subtype involved in neuropeptide-Y-induced food intake Nature 382 6587 1996 168 171 (Pubitemid 26242883)
103. C. Gerald, M.W. Walker, P.J. Vaysse, C. He, T.A. Branchek, and R.L. Weinshank Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype J Biol Chem 270 45 1995 26758 26761
104. K.W. Gillman, M.A. Higgins, G.S. Poindexter, M. Browning, W.J. Clarke, and S. Flowers Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists Bioorg Med Chem 14 16 2006 5517 5526 (Pubitemid 43994480)
105. M.I. Goran Energy metabolism and obesity Med Clin North Am 84 2 2000 347 362 (Pubitemid 30176626)
106. M. Goumain, T. Voisin, A.M. Lorinet, and M. Laburthe Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon Biochem Biophys Res Commun 247 1 1998 52 56 (Pubitemid 28412523)
107. K.R. Grise, A.J. Rongione, E.C. Laird, and D.W. McFadden Peptide YY inhibits growth of human breast cancer in vitro and in vivo J Surg Res 82 2 1999 151 155 (Pubitemid 29394117)
108. E. Grouzmann, T. Buclin, M. Martire, C. Cannizzaro, B. Dorner, and A. Razaname Characterization of a selective antagonist of neuropeptide Y at the Y2 receptor. Synthesis and pharmacological evaluation of a Y2 antagonist J Biol Chem 272 12 1997 7699 7706 (Pubitemid 27137321)
109. Y. Guo, L. Ma, P.J. Enriori, J. Koska, P.W. Franks, and T. Brookshire Physiological evidence for the involvement of peptide YY in the regulation of energy homeostasis in humans Obesity (Silver Spring) 14 9 2006 1562 1570 (Pubitemid 46214823)
110. A. Harfstrand, P. Eneroth, L. Agnati, and K. Fuxe Further studies on the effects of central administration of neuropeptide Y on neuroendocrine function in the male rat: relationship to hypothalamic catecholamines Regul Pept 17 3 1987 167 179 (Pubitemid 17040748)
111. P.J. Havel, J.O. Akpan, D.L. Curry, J.S. Stern, R.L. Gingerich, and B. Ahren Autonomic control of pancreatic polypeptide and glucagon secretion during neuroglucopenia and hypoglycemia in mice Am J Physiol 265 1 Pt 2 1993 R246 R254
112. A.C. Haynes, J.R. Arch, S. Wilson, S. McClue, and R.E. Buckingham Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor? Regul Pept 75-76 1998 355 361 (Pubitemid 28477547)
113. T. Heisler, S. Towfigh, N. Simon, C. Liu, and D.W. McFadden Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth J Surg Res 88 1 2000 23 25 (Pubitemid 30046534)
114. M. Henry, L. Ghibaudi, J. Gao, and J.J. Hwa Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors Obes Res 13 1 2005 36 47
115. H. Herzog Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models Eur J Pharmacol 480 1-3 2003 21 29 (Pubitemid 37410358)
116. H. Herzog, M. Baumgartner, C. Vivero, L.A. Selbie, B. Auer, and J. Shine Genomic organization, localization, and allelic differences in the gene for the human neuropeptide Y Y1 receptor J Biol Chem 268 9 1993 6703 6707 (Pubitemid 23099376)
117. H. Herzog, K. Darby, H. Ball, Y. Hort, A. Beck-Sickinger, and J. Shine Overlapping gene structure of the human neuropeptide Y receptor subtypes Y1 and Y5 suggests coordinate transcriptional regulation Genomics 41 3 1997 315 319 (Pubitemid 27194781)
118. H. Herzog, Y.J. Hort, H.J. Ball, G. Hayes, J. Shine, and L.A. Selbie Cloned human neuropeptide Y receptor couples to two different second messenger systems Proc Natl Acad Sci U S A 89 13 1992 5794 5798
119. H. Higuchi, T. Niki, and T. Shiiya Feeding behavior and gene expression of appetite-related neuropeptides in mice lacking for neuropeptide Y Y5 receptor subclass World J Gastroenterol 14 41 2008 6312 6317
120. P.A. Hipskind, K.L. Lobb, J.A. Nixon, T.C. Britton, R.F. Bruns, and J. Catlow Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists J Med Chem 40 23 1997 3712 3714 (Pubitemid 127744506)
121. A. Hjalmarsen, R.M. Bremnes, U. Aasebo, and R. Jorde Pancreatic polypeptide is increased in patients with advanced malignant disease Anticancer Res 24 4 2004 2515 2517 (Pubitemid 39166340)
122. K.K. Ho, A.J. O'Sullivan, and D.M. Hoffman Metabolic actions of growth hormone in man Endocr J 43 Suppl. 63 1996 S57 S63
123. J.J. Holst, T.W. Schwartz, N.A. Lovgreen, O. Pedersen, and H. Beck-Nielsen Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity Int J Obes 7 6 1983 529 538 (Pubitemid 14239953)
124. Y. Hort, E. Baker, G.R. Sutherland, J. Shine, and H. Herzog Gene duplication of the human peptide YY gene (PYY) generated the pancreatic polypeptide gene (PPY) on chromosome 17q21.1 Genomics 26 1 1995 77 83
125. O.W. Howell, H.E. Scharfman, H. Herzog, L.E. Sundstrom, A. Beck-Sickinger, and W.P. Gray Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells J Neurochem 86 3 2003 646 659 (Pubitemid 36897445)
126. X.F. Huang, M. Han, and L.H. Storlien The level of NPY receptor mRNA expression in diet-induced obese and resistant mice Brain Res Mol Brain Res 115 1 2003 21 28 (Pubitemid 36725032)
127. M.S.B. Huda, J.P. Wilding, and J.H. Pinkney Gut peptides and the regulation of appetite Obes Rev 7 2 2006 163 182
128. J.J. Hwa, M.B. Witten, P. Williams, L. Ghibaudi, J. Gao, and B.G. Salisbury Activation of the NPY Y5 receptor regulates both feeding and energy expenditure Am J Physiol 277 5 Pt 2 1999 R1428 R1434
129. A. Inui, M. Okita, M. Miura, Y. Hirosue, N. Mizuno, and S. Bara Plasma and cerebroventricular fluid levels of pancreatic polypeptide in the dog: effects of feeding, insulin-induced hypoglycemia, and physical exercise Endocrinology 132 3 1993 1235 1239 (Pubitemid 23068643)
130. A. Ishihara, A. Kanatani, S. Mashiko, T. Tanaka, M. Hidaka, and A. Gomori A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice Proc Natl Acad Sci U S A 103 18 2006 7154 7158
131. A. Ishihara, A. Kanatani, M. Okada, M. Hidaka, T. Tanaka, and S. Mashiko Blockade of body weight gain and plasma corticosterone levels in Zucker fatty rats using an orally active neuropeptide Y Y1 antagonist Br J Pharmacol 136 3 2002 341 346 (Pubitemid 34620513)
132. A. Ishihara, T. Tanaka, A. Kanatani, T. Fukami, M. Ihara, and T. Fukuroda A potent neuropeptide Y antagonist, 1229U91, suppressed spontaneous food intake in Zucker fatty rats Am J Physiol 274 5 Pt 2 1998 R1500 R1504
133. A. Jatoi, C.L. Loprinzi, J.A. Sloan, G.G. Klee, and H.E. Windschitl Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation Cancer 92 3 2001 629 633 (Pubitemid 32735199)
134. D.R. Jesudason, M.P. Monteiro, B.M. McGowan, N.M. Neary, A.J. Park, and E. Philippou Low-dose pancreatic polypeptide inhibits food intake in man Br J Nutr 97 3 2007 426 429 (Pubitemid 46662029)
135. N. Kakui, J. Tanaka, Y. Tabata, K. Asai, N. Masuda, and T. Miyara Pharmacological characterization and feeding-suppressive property of FMS586 [3-(5,6,7,8-tetrahydro-9-isopropyl-carbazol-3-yl)-1-methyl-1-(2-pyridin-4-yl- ethyl)-urea hydrochloride], a novel, selective, and orally active antagonist for
136. J. Kallio, U. Pesonen, K. Kaipio, M.K. Karvonen, U. Jaakkola, and O.J. Heinonen Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans Faseb J 15 7 2001 1242 1244
137. S.P. Kalra, M.G. Dube, A. Sahu, C.P. Phelps, and P.S. Kalra Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food Proc Natl Acad Sci U S A 88 23 1991 10931 10935 (Pubitemid 21915953)
138. J. Kamegai, H. Tamura, T. Shimizu, S. Ishii, H. Sugihara, and I. Wakabayashi Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression Endocrinology 141 12 2000 4797 4800 (Pubitemid 32055162)
139. A. Kanatani, M. Hata, S. Mashiko, A. Ishihara, O. Okamoto, and Y. Haga A typical Y1 receptor regulates feeding behaviors: effects of a potent and selective Y1 antagonist, J-115814 Mol Pharmacol 59 3 2001 501 505 (Pubitemid 32179929)
140. A. Kanatani, A. Ishihara, S. Asahi, T. Tanaka, S. Ozaki, and M. Ihara Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake Endocrinology 137 8 1996 3177 3182 (Pubitemid 26250160)
141. A. Kanatani, A. Ishihara, H. Iwaasa, K. Nakamura, O. Okamoto, and M. Hidaka L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist Biochem Biophys Res Commun 272 1 2000 169 173 (Pubitemid 30444917)
142. A. Kanatani, T. Kanno, A. Ishihara, M. Hata, A. Sakuraba, and T. Tanaka The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability Biochem Biophys Res Commun 266 1 1999 88 91 (Pubitemid 30028772)
143. A. Kanatani, S. Mashiko, N. Murai, N. Sugimoto, J. Ito, and T. Fukuroda Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice Endocrinology 141 3 2000 1011 1016 (Pubitemid 32260445)
144. T. Karl, T.H. Burne, and H. Herzog Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety Behav Brain Res 167 1 2006 87 93 (Pubitemid 43063142)
145. M.K. Karvonen, U. Pesonen, M. Koulu, L. Niskanen, M. Laakso, and A. Rissanen Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels Nat Med 4 12 1998 1434 1437 (Pubitemid 28553469)
146. A. Kask, E. Vasar, L.T. Heidmets, L. Allikmets, and J.E. Wikberg Neuropeptide Y Y(5) receptor antagonist CGP71683A: the effects on food intake and anxiety-related behavior in the rat Eur J Pharmacol 414 2-3 2001 215 224 (Pubitemid 32181889)
147. G. Katsuura, A. Asakawa, and A. Inui Roles of pancreatic polypeptide in regulation of food intake Peptides 23 2 2002 323 329 (Pubitemid 34127969)
148. P.J. King, G. Williams, H. Doods, and P.S. Widdowson Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release Eur J Pharmacol 396 1 2000 R1 R3
149. D.A. Kirby, J.H. Boublik, and J.E. Rivier Neuropeptide Y: Y1 and Y2 affinities of the complete series of analogues with single D-residue substitutions J Med Chem 36 24 1993 3802 3808 (Pubitemid 24006708)
150. J. Kitlinska Neuropeptide Y in neural crest-derived tumors: effect on growth and vascularization Cancer Lett 245 1-2 2007 293 302 (Pubitemid 44959356)
151. J. Kitlinska Neuropeptide Y (NPY) in neuroblastoma: effect on growth and vascularization Peptides 28 2 2007 405 412 (Pubitemid 46176254)
152. J. Kitlinska, K. Abe, L. Kuo, J. Pons, M. Yu, and L. Li Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors Cancer Res 65 5 2005 1719 1728 (Pubitemid 40478597)
153. P. Kogner, O. Bjork, and E. Theodorsson Neuropeptide Y as a marker in pediatric neuroblastoma Pediatr Pathol 10 1-2 1990 207 216
154. P. Kogner, O. Bjork, and E. Theodorsson Plasma neuropeptide Y in healthy children: influence of age, anaesthesia and the establishment of an age-adjusted reference interval Acta Paediatr 83 4 1994 423 427 (Pubitemid 24136714)
155. S. Kojima, N. Ueno, A. Asakawa, K. Sagiyama, T. Naruo, and S. Mizuno A role for pancreatic polypeptide in feeding and body weight regulation Peptides 28 2 2007 459 463 (Pubitemid 46176251)
156. M. Korner, B. Waser, and J.C. Reubi High expression of neuropeptide Y1 receptors in ewing sarcoma tumors Clin Cancer Res 14 16 2008 5043 5049
157. J. Koska, A. Delparigi, B. de Courten, C. Weyer, and P.A. Tataranni Pancreatic polypeptide is involved in the regulation of body weight in pima Indian male subjects Diabetes 53 12 2004 3091 3096 (Pubitemid 39564483)
158. C.M. Kotz, J.E. Briggs, M.K. Grace, A.S. Levine, and C.J. Billington Divergence of the feeding and thermogenic pathways influenced by NPY in the hypothalamic PVN of the rat Am J Physiol 275 2 Pt 2 1998 R471 R477
159. J.L. Krstenansky, T.J. Owen, S.H. Buck, K.A. Hagaman, and L.R. McLean Centrally truncated and stabilized porcine neuropeptide Y analogs: design, synthesis, and mouse brain receptor binding Proc Natl Acad Sci U S A 86 12 1989 4377 4381 (Pubitemid 19164558)
160. R. Kuhn, F. Schwenk, M. Aguet, and K. Rajewsky Inducible gene targeting in mice Science 269 5229 1995 1427 1429
161. L.E. Kuo, J.B. Kitlinska, J.U. Tilan, L. Li, S.B. Baker, and M.D. Johnson Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome Nat Med 13 7 2007 803 811 (Pubitemid 47038195)
162. A. Kushi, H. Sasai, H. Koizumi, N. Takeda, M. Yokoyama, and M. Nakamura Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice Proc Natl Acad Sci U S A 95 26 1998 15659 15664 (Pubitemid 29018756)
163. D. Larhammar Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide Regul Pept 62 1 1996 1 11 (Pubitemid 26146193)
164. D. Larhammar, A.G. Blomqvist, F. Yee, E. Jazin, H. Yoo, and C. Wahlestedt Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type J Biol Chem 267 16 1992 10935 10938
165. V. Lassmann, P. Vague, B. Vialettes, and M.C. Simon Low plasma levels of pancreatic polypeptide in obesity Diabetes 29 6 1980 428 430 (Pubitemid 11018461)
166. C. Lavebratt, A. Alpman, B. Persson, P. Arner, and J. Hoffstedt Common neuropeptide Y2 receptor gene variant is protective against obesity among Swedish men Int J Obes (Lond) 30 3 2006 453 459
167. C.W. le Roux, R.L. Batterham, S.J. Aylwin, M. Patterson, C.M. Borg, and K.J. Wynne Attenuated peptide YY release in obese subjects is associated with reduced satiety Endocrinology 147 1 2006 3 8 (Pubitemid 43004254)
168. C.W. le Roux, C.M. Borg, K.G. Murphy, R.P. Vincent, M.A. Ghatei, and S.R. Bloom Supraphysiological doses of intravenous PYY3-36 cause nausea, but no additional reduction in food intake Ann Clin Biochem 45 Pt 1 2008 93 95 (Pubitemid 351724622)
169. N.J. Lee, K.L. Doyle, A. Sainsbury, R.F. Enriquez, Y.J. Hort, and S.J. Riepler Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity J Bone Miner Res 25 8 2010 1736 1747
170. N.J. Lee, R.F. Enriquez, D. Boey, S. Lin, K. Slack, and P.A. Baldock Synergistic attenuation of obesity by Y2- and Y4-receptor double knockout in ob/ob mice Nutrition 24 9 2008 892 899
171. N.J. Lee, A.D. Nguyen, R.F. Enriquez, K.L. Doyle, A. Sainsbury, and P.A. Baldock Osteoblast specific Y1 receptor deletion enhances bone mass Bone 30 2010 30
172. R.L. Leibel, M. Rosenbaum, and J. Hirsch Changes in energy expenditure resulting from altered body weight N Engl J Med 332 10 1995 621 628
173. S.F. Leibowitz, C. Sladek, L. Spencer, and D. Tempel Neuropeptide Y, epinephrine and norepinephrine in the paraventricular nucleus: stimulation of feeding and the release of corticosterone, vasopressin and glucose Brain Res Bull 21 6 1988 905 912 (Pubitemid 19266490)
174. J.A. Levine, N.L. Eberhardt, and M.D. Jensen Role of nonexercise activity thermogenesis in resistance to fat gain in humans Science 283 5399 1999 212 214
175. J.B. Li, A. Asakawa, M. Terashi, K. Cheng, H. Chaolu, and T. Zoshiki Regulatory effects of Y4 receptor agonist (BVD-74D) on food intake Peptides 31 9 2010 1706 1710
176. A.J. Li, and S. Ritter Functional expression of neuropeptide Y receptors in human neuroblastoma cells Regul Pept 129 1-3 2005 119 124 (Pubitemid 40775794)
177. R.J. Lieverse, A.A. Masclee, J.B. Jansen, and C.B. Lamers Plasma cholecystokinin and pancreatic polypeptide secretion in response to bombesin, meal ingestion and modified sham feeding in lean and obese persons Int J Obes Relat Metab Disord 18 2 1994 123 127 (Pubitemid 24056317)
178. S. Lin, D. Boey, M. Couzens, N. Lee, A. Sainsbury, and H. Herzog Compensatory changes in [125I]-PYY binding in Y receptor knockout mice suggest the potential existence of further Y receptor(s) Neuropeptides 39 1 2005 21 28 (Pubitemid 41373325)
179. S. Lin, E.J. Lin, D. Boey, N.J. Lee, K. Slack, and M.J. During Fasting inhibits the growth and reproductive axes via distinct Y2 and Y4 receptor-mediated pathways Endocrinology 148 5 2007 2056 2065 (Pubitemid 46997059)
180. E.J. Lin, A. Sainsbury, N.J. Lee, D. Boey, M. Couzens, and R. Enriquez Combined deletion of Y1, Y2 and Y4 receptors prevents hypothalamic NPY overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity Endocrinology 147 11 2006 5094 5101 (Pubitemid 44790561)
181. S. Lin, Y.C. Shi, E. Yulyaningsih, A. Aljanova, L. Zhang, and L. Macia Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice PLoS One 4 12 2009 e8488
182. S. Lin, L.H. Storlien, and X.F. Huang Leptin receptor, NPY, POMC mRNA expression in the diet-induced obese mouse brain Brain Res 875 1-2 2000 89 95
183. C.D. Liu, A. Balasubramaniam, R.E. Saxton, M. Paiva, and D.W. McFadden Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1 J Surg Res 58 6 1995 707 712
184. C.D. Liu, A.J. Rongione, L. Garvey, A. Balasubramaniam, and D.W. McFadden Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growth Am J Surg 171 1 1996 192 196 (Pubitemid 26029576)
185. Y.L. Liu, N.M. Semjonous, K.G. Murphy, M.A. Ghatei, and S.R. Bloom The effects of pancreatic polypeptide on locomotor activity and food intake in mice Int J Obes (Lond) 32 11 2008 1712 1715
186. C.D. Liu, L.W. Slice, A. Balasubramaniam, J.H. Walsh, T.R. Newton, and R.E. Saxton Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels Surgery 118 2 1995 229 235 (discussion 235-226)
187. C. Lu, L. Everhart, J. Tilan, L. Kuo, C.C. Sun, and R.B. Munivenkatappa Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy Oncogene 2 2010 2
188. D.S. Ludwig, N.A. Tritos, J.W. Mastaitis, R. Kulkarni, E. Kokkotou, and J. Elmquist Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance J Clin Invest 107 3 2001 379 386 (Pubitemid 32157970)
189. P. Lundberg, S.J. Allison, N.J. Lee, P.A. Baldock, N. Brouard, and S. Rost Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1-receptor expression J Biol Chem 282 26 2007 19082 19091 (Pubitemid 47100173)
190. I. Lundell, A.G. Blomqvist, M.M. Berglund, D.A. Schober, D. Johnson, and M.A. Statnick Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY J Biol Chem 270 49 1995 29123 29128
191. G.E. Lunniss, A.A. Barnes, N. Barton, M. Biagetti, F. Bianchi, and S.M. Blowers The identification of a series of novel, soluble non-peptidic neuropeptide Y Y2 receptor antagonists Bioorg Med Chem Lett 10 2010 10
192. J. Ma, H. Li, E. Giovannucci, L. Mucci, W. Qiu, and P.L. Nguyen Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis Lancet Oncol 9 11 2008 1039 1047
193. L. Ma, P.A. Tataranni, R.L. Hanson, A.M. Infante, S. Kobes, and C. Bogardus Variations in peptide YY and Y2 receptor genes are associated with severe obesity in Pima Indian men Diabetes 54 5 2005 1598 1602 (Pubitemid 40586696)
194. D. Mack, G.W. Hacker, C. Hauser-Kronberger, J. Frick, and O. Dietze Vasoactive intestinal polypeptide (VIP) and neuropeptide tyrosine (NPY) in prostate carcinoma Eur J Cancer 33 2 1997 317 318 (Pubitemid 127774313)
195. P.S. MacLean, J.A. Higgins, G.C. Johnson, B.K. Fleming-Elder, W.T. Donahoo, and E.L. Melanson Enhanced metabolic efficiency contributes to weight regain after weight loss in obesity-prone rats Am J Physiol Regul Integr Comp Physiol 287 6 2004 R1306 R1315
196. P. Magni, and M. Motta Expression of neuropeptide Y receptors in human prostate cancer cells Ann Oncol 12 Suppl. 2 2001 S27 S29
197. C. Maier, M. Riedl, G. Vila, P. Nowotny, M. Wolzt, and M. Clodi Cholinergic regulation of ghrelin and peptide YY release may be impaired in obesity Diabetes 57 9 2008 2332 2340
198. I.G. Makarenko, M.M. Meguid, L. Gatto, C. Chen, E.J. Ramos, and C.G. Goncalves Normalization of hypothalamic serotonin (5-HT 1B) receptor and NPY in cancer anorexia after tumor resection: an immunocytochemical study Neurosci Lett 383 3 2005 322 327 (Pubitemid 40805578)
199. I.G. Makarenko, M.M. Meguid, L. Gatto, C. Chen, and M.V. Ugrumov Decreased NPY innervation of the hypothalamic nuclei in rats with cancer anorexia Brain Res 961 1 2003 100 108 (Pubitemid 36084474)
200. F. Malaisse-Lagae, J.L. Carpentier, Y.C. Patel, W.J. Malaisse, and L. Orci Pancreatic polypeptide: a possible role in the regulation of food intake in the mouse. Hypothesis Experientia 33 7 1977 915 917 (Pubitemid 8128835)
201. D. Malis, E. Grouzmann, D.R. Morel, M. Mutter, and J. Lacroix Influence of TASP-V, a novel neuropeptide Y (NPY) Y2 agonist, on nasal and bronchial responses evoked by histamine in anaesthetized pigs and in humans Br J Pharmacol 126 4 1999 989 996 (Pubitemid 29103715)
202. M. Maltoni, O. Nanni, M. Pirovano, E. Scarpi, M. Indelli, and C. Martini Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care J Pain Symptom Manage 17 4 1999 240 247 (Pubitemid 29159966)
203. P.J. Mannon, and J.M. Mele Peptide YY Y1 receptor activates mitogen-activated protein kinase and proliferation in gut epithelial cells via the epidermal growth factor receptor Biochem J 350 Pt 3 2000 655 661
204. J.L. Marks, D. Porte Jr.; W.L. Stahl, and D.G. Baskin Localization of insulin receptor mRNA in rat brain by in situ hybridization Endocrinology 127 6 1990 3234 3236
205. D.J. Marsh, G. Hollopeter, K.E. Kafer, and R.D. Palmiter Role of the Y5 neuropeptide Y receptor in feeding and obesity Nat Med 4 6 1998 718 721 (Pubitemid 28274674)
206. N.M. Martin, C.J. Small, A. Sajedi, M. Patterson, M.A. Ghatei, and S.R. Bloom Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin Int J Obes Relat Metab Disord 28 7 2004 886 893 (Pubitemid 39005689)
207. S. Mashiko, A. Ishihara, H. Iwaasa, R. Moriya, H. Kitazawa, and Y. Mitobe Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine Obesity (Silver Spring) 16 7 2008 1510 1515 (Pubitemid 351915099)
208. S. Mashiko, A. Ishihara, H. Iwaasa, H. Sano, J. Ito, and A. Gomori A pair-feeding study reveals that a Y5 antagonist causes weight loss in diet-induced obese mice by modulating food intake and energy expenditure Mol Pharmacol 71 2 2007 602 608 (Pubitemid 46147924)
209. S. Mashiko, A. Ishihara, H. Iwaasa, H. Sano, Z. Oda, and J. Ito Characterization of neuropeptide Y (NPY) Y5 receptor-mediated obesity in mice: chronic intracerebroventricular infusion of D-Trp(34)NPY Endocrinology 144 5 2003 1793 1801 (Pubitemid 36543317)
210. S. Mashiko, R. Moriya, A. Ishihara, A. Gomori, H. Matsushita, and S. Egashira Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis Eur J Pharmacol 615 1-3 2009 113 117
211. H.D. McCarthy, R.E. Crowder, S. Dryden, and G. Williams Megestrol acetate stimulates food and water intake in the rat: effects on regional hypothalamic neuropeptide Y concentrations Eur J Pharmacol 265 1-2 1994 99 102 (Pubitemid 24341663)
212. K. McCrea, T. Wisialowski, C. Cabrele, B. Church, A. Beck-Sickinger, and E. Kraegen 2-36[K4, RYYSA(19-23)]PP a novel Y5-receptor preferring ligand with strong stimulatory effect on food intake Regul Pept 87 1-3 2000 47 58 (Pubitemid 30068622)
213. J.D. McGarry, S.E. Mills, C.S. Long, and D.W. Foster Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat Biochem J 214 1 1983 21 28 (Pubitemid 13070677)
214. D.M. McTigue, G.E. Hermann, and R.C. Rogers Effect of pancreatic polypeptide on rat dorsal vagal complex neurons J Physiol 499 Pt 2 1997 475 483 (Pubitemid 27129428)
215. D.M. McTigue, and R.C. Rogers Pancreatic polypeptide stimulates gastric acid secretion through a vagal mechanism in rats Am J Physiol 269 5 Pt 2 1995 R983 R987
216. D.M. McTigue, and R.C. Rogers Pancreatic polypeptide stimulates gastric motility through a vagal-dependent mechanism in rats Neurosci Lett 188 2 1995 93 96
217. M.M. Meguid, E.J. Ramos, A. Laviano, M. Varma, T. Sato, and C. Chen Tumor anorexia: effects on neuropeptide Y and monoamines in paraventricular nucleus Peptides 25 2 2004 261 266 (Pubitemid 38520056)
218. R. Mentlein Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides Regul Pept 85 1 1999 9 24 (Pubitemid 29505281)
219. M.C. Michel, A. Beck-Sickinger, H. Cox, H.N. Doods, H. Herzog, and D. Larhammar XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors Pharmacol Rev 50 1 1998 143 150 (Pubitemid 28158845)
220. A. Milewicz, E. Mikulski, and B. Bidzinska Plasma insulin, cholecystokinin, galanin, neuropeptide Y and leptin levels in obese women with and without type 2 diabetes mellitus Int J Obes Relat Metab Disord 24 Suppl. 2 2000 S152 S153
221. G.C. Mitchell, Q. Wang, P. Ramamoorthy, and M.D. Whim A common single nucleotide polymorphism alters the synthesis and secretion of neuropeptide Y J Neurosci 28 53 2008 14428 14434
222. J.H. Moltz, and J.K. McDonald Neuropeptide Y: direct and indirect action on insulin secretion in the rat Peptides 6 6 1985 1155 1159 (Pubitemid 16166869)
223. D.G. Morgan, R.N. Kulkarni, J.D. Hurley, Z.L. Wang, R.M. Wang, and M.A. Ghatei Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells Diabetologia 41 12 1998 1482 1491 (Pubitemid 28551620)
224. S. Movafagh, J.P. Hobson, S. Spiegel, H.K. Kleinman, and Z. Zukowska-Grojec Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors Faseb J 20 11 2006 1924 1926
225. D.E. Mullins, M. Guzzi, L. Xia, and E.M. Parker Pharmacological characterization of the cloned neuropeptide Y y(6) receptor Eur J Pharmacol 395 2 2000 87 93 (Pubitemid 30224810)
226. D. Mullins, D. Kirby, J. Hwa, M. Guzzi, J. Rivier, and E. Parker Identification of potent and selective neuropeptide Y Y(1) receptor agonists with orexigenic activity in vivo Mol Pharmacol 60 3 2001 534 540 (Pubitemid 32781561)
227. D.E. Mullins, X. Zhang, and B.E. Hawes Activation of extracellular signal regulated protein kinase by neuropeptide Y and pancreatic polypeptide in CHO cells expressing the NPY Y(1), Y(2), Y(4) and Y(5) receptor subtypes Regul Pept 105 1 2002 65 73 (Pubitemid 34164384)
228. Y. Murakami, H. Hara, T. Okada, H. Hashizume, M. Kii, and Y. Ishihara 1,3-Disubstituted benzazepines as novel, potent, selective neuropeptide Y Y1 receptor antagonists J Med Chem 42 14 1999 2621 2632 (Pubitemid 29344302)
229. M. Nakazato, N. Murakami, Y. Date, M. Kojima, H. Matsuo, and K. Kangawa A role for ghrelin in the central regulation of feeding Nature 409 6817 2001 194 198 (Pubitemid 32144284)
230. P. Naveilhan, E. Arenas, and P. Ernfors Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system Neuroscience 87 1 1998 289 302 (Pubitemid 28351185)
231. P. Naveilhan, H. Hassani, J.M. Canals, J. Ekstrand, A. Larefalk, and V. Chhajlani Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor Nat Med 5 10 1999 1188 1193 (Pubitemid 29474425)
232. P. Naveilhan, L. Svensson, S. Nystrom, A.J. Ekstrand, and P. Ernfors Attenuation of hypercholesterolemia and hyperglycemia in ob/ob mice by NPY Y2 receptor ablation Peptides 23 6 2002 1087 1091 (Pubitemid 34786296)
233. N.M. Neary, B.M. McGowan, M.P. Monteiro, D.R. Jesudason, M.A. Ghatei, and S.R. Bloom No evidence of an additive inhibitory feeding effect following PP and PYY 3-36 administration Int J Obes (Lond) 32 9 2008 1438 1440
234. T.P. Nedungadi, and K.P. Briski Effects of intracerebroventricular administration of the NPY-Y1 receptor antagonist, 1229U91, on hyperphagic and glycemic responses to acute and chronic intermediate insulin-induced hypoglycemia in female rats Regul Pept 159 1-3 2010 14 18
235. K.A. Nichol, A. Morey, M.H. Couzens, J. Shine, H. Herzog, and A.M. Cunningham Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control J Neurosci 19 23 1999 10295 10304 (Pubitemid 30228037)
236. S. Nordman, B. Ding, C.G. Ostenson, L. Karvestedt, K. Brismar, and S. Efendic Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men Exp Clin Endocrinol Diabetes 113 5 2005 282 287 (Pubitemid 40868184)
237. K.J. Oliveira, G.S.M. Paula, R.H. Gosta-e-Sousa, L.L. Souza, D.C. Moraes, and F.H. Curty Peptide YY (PYY)3-36 modulates thyrotropin secretion in rats J Endocrinol 191 2 2006 459 463 (Pubitemid 44830621)
238. A.A. Ortiz, L.F. Milardo, L.B. DeCarr, T.M. Buckholz, M.R. Mays, and T.H. Claus A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents J Pharmacol Exp Ther 323 2 2007 692 700 (Pubitemid 350005120)
239. E. Ozcivici, Y.K. Luu, B. Adler, Y.X. Qin, J. Rubin, and S. Judex Mechanical signals as anabolic agents in bone Nat Rev Rheumatol 6 1 2010 50 59
240. E. Painsipp, H. Herzog, and P. Holzer Implication of neuropeptide-Y Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice Neuropharmacology 55 1 2008 117 126
241. E.M. Parker, C.K. Babij, A. Balasubramaniam, R.E. Burrier, M. Guzzi, and F. Hamud GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists Eur J Pharmacol 349 1 1998 97 105 (Pubitemid 28270662)
242. E.M. Parker, A. Balasubramaniam, M. Guzzi, D.E. Mullins, B.G. Salisbury, and S. Sheriff [D-Trp(34)] neuropeptide Y is a potent and selective neuropeptide Y Y(5) receptor agonist with dramatic effects on food intake Peptides 21 3 2000 393 399 (Pubitemid 30227679)
243. R.M. Parker, and H. Herzog Regional distribution of Y-receptor subtype mRNAs in rat brain Eur J Neurosci 11 4 1999 1431 1448 (Pubitemid 29142202)
244. R. Parker, and H. Herzog Localization of Y-receptor subtype mRNAs in rat brain by digoxigenin labeled in situ hybridization Methods Mol Biol 153 2000 165 183
245. E. Parker, M. Van Heek, and A. Stamford Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status Eur J Pharmacol 440 2-3 2002 173 187 (Pubitemid 34458022)
246. W.J. Pasman, W.H. Saris, and M.S. Westerterp-Plantenga Predictors of weight maintenance Obes Res 7 1 1999 43 50 (Pubitemid 129710560)
247. T. Pedrazzini, J. Seydoux, P. Kunstner, J.F. Aubert, E. Grouzmann, and F. Beermann Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor Nat Med 4 6 1998 722 726 (Pubitemid 28274675)
248. O. Pieramico, P. Malfertheiner, D.K. Nelson, B. Glasbrenner, and H. Ditschuneit Interdigestive cycling and post-prandial release of pancreatic polypeptide in severe obesity Int J Obes 14 12 1990 1005 1011
249. D.D. Pierroz, C. Catzeflis, A.C. Aebi, J.E. Rivier, and M.L. Aubert Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats Endocrinology 137 1 1996 3 12
250. M. Pirovano, M. Maltoni, O. Nanni, M. Marinari, M. Indelli, and G. Zaninetta A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care J Pain Symptom Manage 17 4 1999 231 239 (Pubitemid 29159965)
251. R.A. Pittner, C.X. Moore, S.P. Bhavsar, B.R. Gedulin, P.A. Smith, and C.M. Jodka Effects of PYY[3-36] in rodent models of diabetes and obesity Int J Obes Relat Metab Disord 28 8 2004 963 971 (Pubitemid 38998700)
252. F.P. Pralong, C. Gonzales, M.J. Voirol, R.D. Palmiter, H.R. Brunner, and R.C. Gaillard The neuropeptide Y Y1 receptor regulates leptin-mediated control of energy homeostasis and reproductive functions Faseb J 16 7 2002 712 714
253. O.J. Ramo, A. Balasubramaniam, S. Sheriff, D.H. Rogers, P.J. McCullough, and R.H. Bell Jr. Neuropeptide Y and peptide YY stimulate the growth of exocrine pancreatic carcinoma cells Neuropeptides 15 2 1990 101 106 (Pubitemid 20047876)
254. P.D. Raposinho, D.D. Pierroz, P. Broqua, R.B. White, T. Pedrazzini, and M.L. Aubert Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism Mol Cell Endocrinol 185 1-2 2001 195 204 (Pubitemid 33103968)
255. J.P. Redrobe, Y. Dumont, J.A. St-Pierre, and R. Quirion Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition Brain Res 848 1-2 1999 153 166 (Pubitemid 30001664)
256. R.D. Reidelberger, A.C. Haver, P.K. Chelikani, and J.L. Buescher Effects of different intermittent peptide YY (3-36) dosing strategies on food intake, body weight, and adiposity in diet-induced obese rats Am J Physiol Regul Integr Comp Physiol 295 2 2008 R449 R458
257. A.G. Renehan Bariatric surgery, weight reduction, and cancer prevention Lancet Oncol 10 7 2009 640 641
258. D. Renshaw, and R.L. Batterham Peptide YY: a potential therapy for obesity Curr Drug Targets 6 2 2005 171 179 (Pubitemid 40394312)
259. J.C. Reubi, M. Gugger, B. Waser, and J.C. Schaer Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets Cancer Res 61 11 2001 4636 4641 (Pubitemid 32685800)
260. S.B. Roberts, V.R. Young, P. Fuss, M.A. Fiatarone, B. Richard, and H. Rasmussen Energy expenditure and subsequent nutrient intakes in overfed young men Am J Physiol 259 3 Pt 2 1990 R461 R469
261. M. Rosenbaum, J. Hirsch, E. Murphy, and R.L. Leibel Effects of changes in body weight on carbohydrate metabolism, catecholamine excretion, and thyroid function Am J Clin Nutr 71 6 2000 1421 1432 (Pubitemid 30395887)
262. C.L. Roth, P.J. Enriori, K. Harz, J. Woelfle, M.A. Cowley, and T. Reinehr Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss J Clin Endocrinol Metab 90 12 2005 6386 6391 (Pubitemid 41759289)
263. K. Rudolf, W. Eberlein, W. Engel, H.A. Wieland, K.D. Willim, and M. Entzeroth The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226 Eur J Pharmacol 271 2-3 1994 R11 R13
264. M. Ruscica, E. Dozio, S. Boghossian, G. Bovo, V.M. Riano, and M. Motta Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells Endocrinology 147 3 2006 1466 1473 (Pubitemid 43244381)
265. M. Ruscica, E. Dozio, M. Motta, and P. Magni Role of neuropeptide Y and its receptors in the progression of endocrine-related cancer Peptides 28 2 2007 426 434 (Pubitemid 46176277)
266. A. Sainsbury, P.A. Baldock, C. Schwarzer, N. Ueno, R.F. Enriquez, and M. Couzens Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice Mol Cell Biol 23 15 2003 5225 5233 (Pubitemid 36950878)
267. A. Sainsbury, H.T. Bergen, D. Boey, D. Bamming, G.J. Cooney, and S. Lin Y2Y4 receptor double knockout protects against obesity due to a high-fat diet or Y1 receptor deficiency in mice Diabetes 55 1 2006 19 26 (Pubitemid 43343295)
268. A. Sainsbury, G.J. Cooney, and H. Herzog Hypothalamic regulation of energy homeostasis Best Pract Res Clin Endocrinol Metab 16 4 2002 623 637
269. A. Sainsbury, I. Cusin, F. Rohner-Jeanrenaud, and B. Jeanrenaud Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats Diabetes 46 2 1997 209 214 (Pubitemid 27272253)
270. A. Sainsbury, and H. Herzog Inhibitory effects of central neuropeptide Y on the somatotropic and gonadotropic axes in male rats are independent of adrenal hormones Peptides 22 3 2001 467 471 (Pubitemid 32250249)
271. A. Sainsbury, F. Rohner-Jeanrenaud, I. Cusin, K.E. Zakrzewska, P.A. Halban, and R.C. Gaillard Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia Diabetologia 40 11 1997 1269 1277 (Pubitemid 27469666)
272. A. Sainsbury, C. Schwarzer, M. Couzens, S. Fetissov, S. Furtinger, and A. Jenkins Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice Proc Natl Acad Sci U S A 99 13 2002 8938 8943 (Pubitemid 34693662)
273. A. Sainsbury, C. Schwarzer, M. Couzens, and H. Herzog Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice Diabetes 51 12 2002 3420 3427 (Pubitemid 35403445)
274. A. Sainsbury, C. Schwarzer, M. Couzens, A. Jenkins, S.R. Oakes, and C.J. Ormandy Y4 receptor knockout rescues fertility in ob/ob mice Genes Dev 16 9 2002 1077 1088 (Pubitemid 34507197)
275. A. Sainsbury, and L. Zhang Role of the arcuate nucleus of the hypothalamus in regulation of body weight during energy deficit Mol Cell Endocrinol 12 2009 12
276. P.T. Schmidt, E. Naslund, P. Gryback, H. Jacobsson, J.J. Holst, and L. Hilsted A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control J Clin Endocrinol Metab 90 9 2005 5241 5246 (Pubitemid 41262281)
277. S. Schonhoff, L. Baggio, C. Ratineau, S.K. Ray, J. Lindner, and M.A.
278. T.W. Schwartz, J.J. Holst, J. Fahrenkrug, S.L. Jensen, O.V. Nielsen, and J.F. Rehfeld Vagal, cholinergic regulation of pancreatic polypeptide secretion J Clin Invest 61 3 1978 781 789
279. M.W. Schwartz, A.J. Sipols, J.L. Marks, G. Sanacora, J.D. White, and A. Scheurink Inhibition of hypothalamic neuropeptide Y gene expression by insulin Endocrinology 130 6 1992 3608 3616
280. V. Scott, N. Kimura, J.A. Stark, and S.M. Luckman Intravenous peptide YY3-36 and Y2 receptor antagonism in the rat: effects on feeding behaviour J Neuroendocrinol 17 7 2005 452 457 (Pubitemid 40873282)
281. V. Sergeyev, C. Broberger, O. Gorbatyuk, and T. Hokfelt Effect of 2-mercaptoacetate and 2-deoxy-d-glucose administration on the expression of NPY, AGRP, POMC, MCH and hypocretin/orexin in the rat hypothalamus Neuroreport 11 1 2000 117 121 (Pubitemid 30053401)
282. C. Serradeil-Le Gal, M. Lafontan, D. Raufaste, J. Marchand, B. Pouzet, and P. Casellas Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes FEBS Lett 475 2 2000 150 156 (Pubitemid 30365069)
283. C. Serradeil-Le Gal, G. Valette, P.E. Rouby, A. Pellet, F. Oury-Donat, and G. Brossard SR 120819A, an orally-active and selective neuropeptide Y Y1 receptor antagonist FEBS Lett 362 2 1995 192 196
284. S. Sheriff, M. Ali, A. Yahya, K.H. Haider, A. Balasubramaniam, and H. Amlal Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line Mol Cancer Res 8 4 2010 604 614
285. S. Sheriff, W.T. Chance, J.E. Fischer, and A. Balasubramaniam Neuropeptide Y treatment and food deprivation increase cyclic AMP response element-binding in rat hypothalamus Mol Pharmacol 51 4 1997 597 604 (Pubitemid 27172986)
286. Y.C. Shi, S. Lin, I.P. Wong, P.A. Baldock, A. Aljanova, and R.F. Enriquez NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice PLoS One 5 6 2010 e11361
287. M. Shintani, Y. Ogawa, K. Ebihara, M. Aizawa-Abe, F. Miyanaga, and K. Takaya Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway Diabetes 50 2 2001 227 232 (Pubitemid 32127276)
288. Shionogi, and L. Co Shionogi announces positive top-line efficacy results from year-long studies of velneperit, a novel NPY Y5 receptor antagonist being investigated for the treatment of obesity Retrieved December 9, 2010, from http://www.shionogi.co.jp/ir-en/news/detail/e-090217-2.pdf 2009, Febrary 17
289. A. Siddiq, M. Gueorguiev, C. Samson, S. Hercberg, B. Heude, and C. Levy-Marchal Single nucleotide polymorphisms in the neuropeptide Y2 receptor (NPY2R) gene and association with severe obesity in French white subjects Diabetologia 50 3 2007 574 584 (Pubitemid 46215501)
290. J.E. Silva Thermogenic mechanisms and their hormonal regulation Physiol Rev 86 2 2006 435 464
291. A.A. Sive, A.L. Vinik, and S.V. van Tonder Pancreatic polypeptide (PP) responses to oral and intravenous glucose in man Am J Gastroenterol 71 2 1979 183 185 (Pubitemid 9140100)
292. B. Sloth, L. Davidsen, J.J. Holst, A. Flint, and A. Astrup Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males Am J Physiol Endocrinol Metab 293 2 2007 E604 E609
293. B. Sloth, J.J. Holst, A. Flint, N.T. Gregersen, and A. Astrup Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects Am J Physiol Endocrinol Metab 292 4 2007 E1062 E1068
294. C.J. Small, D.G. Morgan, K. Meeran, M.M. Heath, I. Gunn, and C.M.B. Edwards Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release Proc Natl Acad Sci U S A 94 21 1997 11686 11691 (Pubitemid 27451059)
295. M.A. Smith-White, T.A. Hardy, J.A. Brock, and E.K. Potter Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions Br J Pharmacol 132 4 2001 861 868 (Pubitemid 32193643)
296. R.M. Soll, M.C. Dinger, I. Lundell, D. Larhammer, and A.G. Beck-Sickinger Novel analogues of neuropeptide Y with a preference for the Y1-receptor Eur J Biochem 268 10 2001 2828 2837 (Pubitemid 32862965)
297. J.M. Stafford, F. Yu, R. Printz, A.H. Hasty, L.L. Swift, and K.D. Niswender Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion Diabetes 57 6 2008 1482 1490
298. B.G. Stanley, S.E. Kyrkouli, S. Lampert, and S.F. Leibowitz Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity Peptides 7 6 1986 1189 1192 (Pubitemid 17226746)
299. T.W. Stephens, M. Basinski, P.K. Bristow, J.M. Bue-Valleskey, S.G. Burgett, and L. Craft The role of neuropeptide Y in the antiobesity action of the obese gene product Nature 377 6549 1995 530 532
300. S. Stock, P. Leichner, A.C.K. Wong, M.A. Ghatei, T.J. Kieffer, and S.R. Bloom Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents J Clin Endocrinol Metab 90 4 2005 2161 2168 (Pubitemid 40586256)
301. Z. Szreder, T. Hori, and Y. Kaizuka Thermoregulatory effect of intracerebral injections of neuropeptide Y in rats at different environmental temperatures Gen Pharmacol 25 1 1994 85 91 (Pubitemid 24055415)
302. K. Takahashi, T. Mouri, K. Itoi, M. Sone, M. Ohneda, and O. Murakami Increased plasma immunoreactive neuropeptide Y concentrations in phaeochromocytoma and chronic renal failure J Hypertens 5 6 1987 749 753 (Pubitemid 18029959)
303. T. Talsania, Y. Anini, S. Siu, D.J. Drucker, and P.L. Brubaker Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice Endocrinology 146 9 2005 3748 3756 (Pubitemid 41175742)
304. I.L. Taylor, and R. Garcia Effects of pancreatic polypeptide, caerulein, and bombesin on satiety in obese mice Am J Physiol 248 3 Pt 1 1985 G277 G280
305. I.L. Taylor, M. Impicciatore, D.C. Carter, and J.H. Walsh Effect of atropine and vagotomy on pancreatic polypeptide response to a meal in dogs Am J Physiol 235 4 1978 E443 E447
306. T. Tomita, G.H. Greeley Jr.; V. Doull, and R. Chance Protein meal-stimulated pancreatic polypeptide secretion in Prader-Willi syndrome of adults Pancreas 4 4 1989 395 400 (Pubitemid 19202791)
307. S.S. Torekov, L.H. Larsen, G. Andersen, A. Albrechtsen, C. Glumer, and K. Borch-Johnsen Variants in the 5′ region of the neuropeptide Y receptor Y2 gene (NPY2R) are associated with obesity in 5,971 white subjects Diabetologia 49 11 2006 2653 2658 (Pubitemid 44559527)
308. N.S. Track, R.S. McLeod, and A.V. Mee Human pancreatic polypeptide: studies of fasting and postprandial plasma concentrations Can J Physiol Pharmacol 58 12 1980 1484 1489 (Pubitemid 11146508)
309. P.G. Trivedi, H. Yu, M. Trumbauer, H. Chen, L.H. Van der Ploeg, and X. Guan Differential regulation of neuropeptide Y receptors in the brains of NPY knock-out mice Peptides 22 3 2001 395 403 (Pubitemid 32250240)
310. A.V. Turnbull, L. Ellershaw, D.J. Masters, S. Birtles, S. Boyer, and D. Carroll Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats Diabetes 51 8 2002 2441 2449 (Pubitemid 34827392)
311. N. Turner, C.R. Bruce, S.M. Beale, K.L. Hoehn, T. So, and M.S. Rolph Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents Diabetes 56 8 2007 2085 2092 (Pubitemid 47195821)
312. N. Ueno, A. Inui, M. Iwamoto, T. Kaga, A. Asakawa, and M. Okita Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice Gastroenterology 117 6 1999 1427 1432
313. A.M. Uhe, G.I. Szmukler, G.R. Collier, J. Hasky, K. O'Dea, and G.P. Young Potential regulators of feeding behavior in anorexia nervosa Am J Clin Nutr 55 1 1992 28 32
314. O. Ukkola, and Y.A. Kesaniemi Leu7Pro polymorphism of preproNPY associated with an increased risk for type II diabetes in middle-aged subjects Eur J Clin Nutr 61 9 2007 1102 1105 (Pubitemid 47386596)
315. S. Unniappan, C.H. McIntosh, H.U. Demuth, U. Heiser, R. Wolf, and T.J. Kieffer Effects of dipeptidyl peptidase IV on the satiety actions of peptide YY Diabetologia 49 8 2006 1915 1923 (Pubitemid 44025047)
316. P. Valet, M. Berlan, M. Beauville, F. Crampes, J.L. Montastruc, and M. Lafontan Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein J Clin Invest 85 1 1990 291 295 (Pubitemid 20030321)
317. A.M. van den Hoek, A.C. Heijboer, E.P. Corssmit, P.J. Voshol, J.A. Romijn, and L.M. Havekes PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet Diabetes 53 8 2004 1949 1952 (Pubitemid 38970740)
318. A.M. van den Hoek, A.C. Heijboer, P.J. Voshol, L.M. Havekes, J.A. Romijn, and E.P. Corssmit Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice Am J Physiol Endocrinol Metab 292 1 2007 E238 E245
319. N. Vrang, A.N. Madsen, M. Tang-Christensen, G. Hansen, and P.J. Larsen PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity Am J Physiol Regul Integr Comp Physiol 291 2 2006 R367 R375
320. G. Waeber, N. Thompson, B. Waeber, H.R. Brunner, P. Nicod, and E. Grouzmann Neuropeptide Y expression and regulation in a differentiated rat insulin-secreting cell line Endocrinology 133 3 1993 1061 1067 (Pubitemid 23267755)
321. C. Wahlestedt, G. Skagerberg, R. Ekman, M. Heilig, F. Sundler, and R. Hakanson Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat Brain Res 417 1 1987 33 38 (Pubitemid 18012253)
322. C. Wahlestedt, N. Yanaihara, and R. Hakanson Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides Regul Pept 13 3-4 1986 307 318 (Pubitemid 16160258)
323. S.M. Wallerstedt, S. Skrtic, A.L. Eriksson, C. Ohlsson, and T. Hedner Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive population J Hypertens 22 7 2004 1277 1281 (Pubitemid 38888072)
324. Z.L. Wang, W.M. Bennet, R.M. Wang, M.A. Ghatei, and S.R. Bloom Evidence of a paracrine role of neuropeptide-Y in the regulation of insulin release from pancreatic islets of normal and dexamethasone-treated rats Endocrinology 135 1 1994 200 206 (Pubitemid 24203817)
325. C. Wang, N. Yang, S. Wu, L. Liu, X. Sun, and S. Nie Difference of NPY and its receptor gene expressions between obesity and obesity-resistant rats in response to high-fat diet Horm Metab Res 39 4 2007 262 267 (Pubitemid 46715883)
326. J. Wheway, H. Herzog, and F. Mackay The Y1 receptor for NPY: a key modulator of the adaptive immune system Peptides 28 2 2007 453 458 (Pubitemid 46176271)
327. J. Wheway, H. Herzog, and F. Mackay NPY and receptors in immune and inflammatory diseases Curr Top Med Chem 7 17 2007 1743 1752 (Pubitemid 350131011)
328. H.A. Wieland, W. Engel, W. Eberlein, K. Rudolf, and H.N. Doods Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents Br J Pharmacol 125 3 1998 549 555 (Pubitemid 28451494)
329. H.A. Wieland, K.D. Willim, M. Entzeroth, W. Wienen, K. Rudolf, and W. Eberlein Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226 J Pharmacol Exp Ther 275 1 1995 143 149
330. M.G. Willesen, P. Kristensen, and J. Romer Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat Neuroendocrinology 70 5 1999 306 316
331. O. Wisen, H. Bjorvell, P. Cantor, C. Johansson, and E. Theodorsson Plasma concentrations of regulatory peptides in obesity following modified sham feeding (MSF) and a liquid test meal Regul Pept 39 1 1992 43 54
332. W. Wittmann, S. Loacker, I. Kapeller, H. Herzog, and C. Schwarzer Y1-receptors regulate the expression of Y2-receptors in distinct mouse forebrain areas Neuroscience 136 1 2005 241 250 (Pubitemid 41483851)
333. K.E. Wortley, K. Garcia, H. Okamoto, K. Thabet, K.D. Anderson, and V. Shen Peptide YY regulates bone turnover in rodents Gastroenterology 133 5 2007 1534 1543 (Pubitemid 350029744)
334. P. Wyss, A. Stricker-Krongrad, L. Brunner, J. Miller, A. Crossthwaite, and S. Whitebread The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes Regul Pept 75-76 1998 363 371 (Pubitemid 28477548)
335. K. Yang, H. Guan, E. Arany, D.J. Hill, and X. Cao Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor Faseb J 7 2008 7
336. Y. Yu, C. Deng, and X.F. Huang Obese reversal by a chronic energy restricted diet leaves an increased Arc NPY/AgRP, but no alteration in POMC/CART, mRNA expression in diet-induced obese mice Behav Brain Res 205 1 2009 50 56
337. A. Yu, P. Somasundar, A. Balsubramaniam, A.T. Rose, L. Vona-Davis, and D.W. McFadden Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor J Surg Res 105 1 2002 65 68 (Pubitemid 34713214)
338. N. Zarjevski, I. Cusin, R. Vettor, F. Rohner-Jeanrenaud, and B. Jeanrenaud Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity Endocrinology 133 4 1993 1753 1758 (Pubitemid 23295205)
339. N. Zarjevski, I. Cusin, R. Vettor, F. Rohner-Jeanrenaud, and B. Jeanrenaud Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle Diabetes 43 6 1994 764 769 (Pubitemid 24166351)
340. L. Zhang, L. Macia, N. Turner, R.F. Enriquez, S.J. Riepler, and A.D. Nguyen Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion Int J Obes (Lond) 34 2 2010 357 373
341. L. Zhang, S.J. Riepler, N. Turner, R.F. Enriquez, I.C. Lee, and H. Herzog Y2 and Y4 receptor signalling synergistically act on energy expenditure and physical activity Am J Physiol Regul Integr Comp Physiol 29 2010 29
342. D.M. Zimmerman, B.E. Cantrell, E.C. Smith, J.A. Nixon, R.F. Bruns, and B. Gitter Structure-activity relationships of a series of 1-substituted-4- methylbenzimidazole neuropeptide Y-1 receptor antagonists Bioorg Med Chem Lett 8 5 1998 473 476 (Pubitemid 28092377)
343. W.B. Zipf, T.M. O'Dorisio, S. Cataland, and K. Dixon Pancreatic polypeptide responses to protein meal challenges in obese but otherwise normal children and obese children with Prader-Willi syndrome J Clin Endocrinol Metab 57 5 1983 1074 1080 (Pubitemid 14204314)
344. W.B. Zipf, T.M. O'Dorisio, S. Cataland, and J. Sotos Blunted pancreatic polypeptide responses in children with obesity of Prader-Willi syndrome J Clin Endocrinol Metab 52 6 1981 1264 1266 (Pubitemid 13237538)